INPATIENT USE OF BENRALIZUMAB IN ACUTE SEVERE EOSINOPHILIC ASTHMA

被引：0
|
作者：
Toth, Stephen
Pruett, William M.
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
10.1016/j.chest.2024.06.067
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：79A / 79A
页数：1
相关论文
共 50 条
  • [21] BENRALIZUMAB IMPROVES RESPIRATORY RESISTANCE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Badal, T.
    Cottee, A.
    Seccombe, L.
    Reed, N.
    Farah, C.
    RESPIROLOGY, 2020, 25 : 210 - 210
  • [22] Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma
    Pelaia, Corrado
    Calabrese, Cecilia
    Vatrella, Alessandro
    Busceti, Maria Teresa
    Garofalo, Eugenio
    Lombardo, Nicola
    Terracciano, Rosa
    Pelaia, Girolamo
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [23] Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
    Martinez-Rivera, Carlos
    Garcia-Olive, Ignasi
    Urrutia-Royo, Blanca
    Basagana-Torrento, Maria
    Rosell, Antoni
    Abad, Jorge
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [24] Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
    Carlos Martínez-Rivera
    Ignasi Garcia-Olivé
    Blanca Urrutia-Royo
    Maria Basagaña-Torrento
    Antoni Rosell
    Jorge Abad
    BMC Pulmonary Medicine, 21
  • [25] Mepolizumab and Benralizumab: new therapeutic perspectives for Severe Eosinophilic Asthma and Eosinophilic Granulomatosis with Polyangiitis
    Scarano, Paola
    Cisternino, Cecilia
    Lo Muzio, Giulia
    Calo, Olimpia
    Sanna, Arianna
    Steffanina, Alessia
    De Filippis, Francesca
    Leporini, Maria Teresa
    Palange, Paolo
    Graziani, Elda
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [26] Successful treatment of an elderly patient with severe eosinophilic asthma and eosinophilic myocarditis using benralizumab
    Kodaka, Norio
    Nakano, Chihiro
    Oshio, Takeshi
    Hirouchi, Takatomo
    Satou, Manabu
    Moroi, Masao
    Oharaseki, Toshiaki
    Matsuse, Hiroto
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2022, 22 (02) : 175 - 176
  • [27] Personalized Approach of Severe Eosinophilic Asthma Patients Treated with Mepolizumab and Benralizumab
    Bergantini, Laura
    d'Alessandro, Miriana
    Cameli, Paolo
    Bianchi, Francesco
    Sestini, Piersante
    Bargagli, Elena
    Refini, Rosa Metella
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2020, 181 (10) : 746 - 753
  • [28] COMPREHENSIVE RESPONSE TO BENRALIZUMAB BY PATIENTS WITH NASAL POLYPOSIS AND SEVERE, EOSINOPHILIC ASTHMA
    Kreindler, J.
    Chanez, P.
    Bourdin, A.
    Burden, A.
    Garcia Gil, E.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S29 - S29
  • [29] Relationship Between Benralizumab Exposure and Efficacy for Patients With Severe Eosinophilic Asthma
    Chia, Yen Lin
    Yan, Li
    Yu, Binbing
    Wang, Bing
    Barker, Peter
    Goldman, Mitchell
    Roskos, Lorin
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (02) : 383 - 390
  • [30] COST-UTILITY ANALYSIS OF BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA IN PANAMA
    Ordonez, J.
    Ordonez, A.
    Hidalgo Godinez, J.
    Buitrago, R.
    VALUE IN HEALTH, 2022, 25 (07) : S422 - S423
12345